News

LIKE MANY OTHER PROVIDERS, NP TO-GO OFFERED THEIR PATIENTS COPYCAT VERSIONS OF THE SEMAGLUTIDE FROM COMPOUNDING PHARMACIES, BUT THAT HAS COME TO A HALT AFTER THE FDA DECLARED THERE WAS NO LONGER A ...
The government has increased the dearness allowance from 53% to 55% of basic pay with retrospective payment from January 1, 2025. The dearness allowance hike will increase gross earnings and provident ...
Share dilution decreases value per existing share by adding more shares to the market. Earnings per share lower post-dilution, impacting investment value negatively. Investor awareness of SBC and ...
Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...
You can use Wegovy (semaglutide) as long as you need for weight loss and weight management. You can continue taking Wegovy if you and your doctor determine that Wegovy is safe for you and you can ...
The Ministry of Health has registered the seventh semaglutide drug from Russian pharmaceutical companies, an analogue of Novo Nordisk’s blockbuster Ozempiс. The new drug, Segluria, is manufactured by ...
Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date ...
While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire across the globe and make inroads into large markets like Brazil.
Using real-world data from over 300,000 cases, scientists uncovered a significant link between semaglutide and reported vision problems—raising new concerns about the safety profile of this ...
Semaglutide (the active ingredient in Ozempic and Wegovy) is commonly used to treat type 2 diabetes and obesity. © Starmarpro via Shutterstock The case for Ozempic ...
President Donald Trump holds up a report authored by the Office of the U.S. Trade Representative that he cited as instrumental in his tariff policy.
Semaglutide brand names include Ozempic, Rybelus, and Wegovy, all made by Novo Nordisk, and Mounjaro from Eli Lilly. The study, led by the Centers for Disease Control and Prevention and Cambridge ...